TRex Bio, Inc. develops immunoregulatory biologics for autoimmune and inflammatory diseases. The company operates the Deep Biology Platform, a drug discovery and design platform that integrates tissue-level insights into human biology and Treg function to identify and characterize therapeutic...
3 insider purchases on record · latest filing 2026-10-15.